4//SEC Filing
Dier Mardi 4
Accession 0001628280-25-010508
CIK 0001157601other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:31 PM ET
Size
7.1 KB
Accession
0001628280-25-010508
Insider Transaction Report
Form 4
Dier Mardi
SVP and CFO
Transactions
- Sale
Common Stock
2025-03-03$325.89/sh−1,187$386,831→ 7,688 total - Sale
Common Stock
2025-03-03$323.54/sh−774$250,417→ 6,914 total
Footnotes (3)
- [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.38 to $323.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001574591
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:31 PM ET
- Size
- 7.1 KB